MedTrace Logo

Catechin Gargling for Influenza Infection

NCT00239213 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2006-10-31

No results posted yet for this study

Summary

The purpose of this study is to clarify the preventive effects of catechin gargling on the influenza infection.

Conditions

  • Influenza Infection

Interventions

DRUG

catechin extracts (health food)

Sponsors & Collaborators

  • Shizuoka General Hospital

    collaborator UNKNOWN

  • Seirei Hamamatsu General Hospital

    collaborator OTHER

  • White Cross Nursing Home

    collaborator OTHER

  • University of Shizuoka

    lead OTHER

Principal Investigators

  • Hiroshi Yamada, MD, PhD · University of Shizuoka

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Completion
2006-04-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239213 on ClinicalTrials.gov